Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $80.61 billion. The enterprise value is $88.90 billion.
| Market Cap | 80.61B |
| Enterprise Value | 88.90B |
Important Dates
The last earnings date was Wednesday, April 22, 2026, before market open.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.49 billion shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 1.49B |
| Shares Outstanding | 1.49B |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 91.73% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 22.33 and the forward PE ratio is 15.40. BSX's PEG ratio is 1.00.
| PE Ratio | 22.33 |
| Forward PE | 15.40 |
| PS Ratio | 3.85 |
| Forward PS | 3.50 |
| PB Ratio | 3.07 |
| P/TBV Ratio | 296.00 |
| P/FCF Ratio | 22.83 |
| P/OCF Ratio | 18.27 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.16, with an EV/FCF ratio of 25.58.
| EV / Earnings | 24.94 |
| EV / Sales | 4.31 |
| EV / EBITDA | 16.16 |
| EV / EBIT | 21.65 |
| EV / FCF | 25.58 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.90 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.01 |
| Debt / FCF | 3.17 |
| Interest Coverage | 11.50 |
Financial Efficiency
Return on equity (ROE) is 14.66% and return on invested capital (ROIC) is 11.13%.
| Return on Equity (ROE) | 14.66% |
| Return on Assets (ROA) | 6.07% |
| Return on Invested Capital (ROIC) | 11.13% |
| Return on Capital Employed (ROCE) | 10.32% |
| Weighted Average Cost of Capital (WACC) | 7.12% |
| Revenue Per Employee | $349,390 |
| Profits Per Employee | $60,424 |
| Employee Count | 59,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, BSX has paid $184.00 million in taxes.
| Income Tax | 184.00M |
| Effective Tax Rate | 4.92% |
Stock Price Statistics
The stock price has decreased by -47.65% in the last 52 weeks. The beta is 0.62, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -47.65% |
| 50-Day Moving Average | 64.14 |
| 200-Day Moving Average | 88.25 |
| Relative Strength Index (RSI) | 31.43 |
| Average Volume (20 Days) | 18,583,006 |
Short Selling Information
The latest short interest is 25.61 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 25.61M |
| Short Previous Month | 25.44M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 1.73% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, BSX had revenue of $20.61 billion and earned $3.57 billion in profits. Earnings per share was $2.39.
| Revenue | 20.61B |
| Gross Profit | 14.21B |
| Operating Income | 4.11B |
| Pretax Income | 3.74B |
| Net Income | 3.57B |
| EBITDA | 5.50B |
| EBIT | 4.11B |
| Earnings Per Share (EPS) | $2.39 |
Balance Sheet
The company has $1.45 billion in cash and $11.03 billion in debt, with a net cash position of -$9.58 billion or -$6.44 per share.
| Cash & Cash Equivalents | 1.45B |
| Total Debt | 11.03B |
| Net Cash | -9.58B |
| Net Cash Per Share | -$6.44 |
| Equity (Book Value) | 26.10B |
| Book Value Per Share | 17.40 |
| Working Capital | 4.11B |
Cash Flow
In the last 12 months, operating cash flow was $4.34 billion and capital expenditures -$866.00 million, giving a free cash flow of $3.48 billion.
| Operating Cash Flow | 4.34B |
| Capital Expenditures | -866.00M |
| Depreciation & Amortization | 1.39B |
| Net Borrowing | -997.00M |
| Free Cash Flow | 3.48B |
| FCF Per Share | $2.34 |
Margins
Gross margin is 68.94%, with operating and profit margins of 19.92% and 17.29%.
| Gross Margin | 68.94% |
| Operating Margin | 19.92% |
| Pretax Margin | 18.16% |
| Profit Margin | 17.29% |
| EBITDA Margin | 26.68% |
| EBIT Margin | 19.92% |
| FCF Margin | 16.86% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.42% |
| Shareholder Yield | -0.42% |
| Earnings Yield | 4.49% |
| FCF Yield | 4.38% |
Analyst Forecast
The average price target for BSX is $93.18, which is 71.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $93.18 |
| Price Target Difference | 71.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 10.65% |
| EPS Growth Forecast (5Y) | 20.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.77 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.77 |
| Piotroski F-Score | 7 |